AT510991A5 - Peptide für die Inhibition MyD88-abhängiger Signalwege - Google Patents

Peptide für die Inhibition MyD88-abhängiger Signalwege Download PDF

Info

Publication number
AT510991A5
AT510991A5 ATA9494/2009A AT94942009A AT510991A5 AT 510991 A5 AT510991 A5 AT 510991A5 AT 94942009 A AT94942009 A AT 94942009A AT 510991 A5 AT510991 A5 AT 510991A5
Authority
AT
Austria
Prior art keywords
myd88
inhibition
peptides
signaling pathways
dependent signaling
Prior art date
Application number
ATA9494/2009A
Other languages
English (en)
Other versions
AT510991A2 (de
Original Assignee
Kemijski Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kemijski Inst filed Critical Kemijski Inst
Publication of AT510991A2 publication Critical patent/AT510991A2/de
Publication of AT510991A5 publication Critical patent/AT510991A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Hemmpeptide (inhibitorische Peptide) für die Inhibition MyD88-abhängiger Signalwege Der Bereich der Erfindung ist ein neues Hemmpeptid mit einem Segment zur Inhibition der MyD88-Aktivierung. Die Erfindung umfasst das Hemmpeptid und seine Verwendung zur Heilung von Krankheitszuständen, die mit einer übermäßigen angeborenen lmmunsystemreaktion verbunden sind.
ATA9494/2009A 2009-10-09 2009-10-09 Peptide für die Inhibition MyD88-abhängiger Signalwege AT510991A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/SI2009/000046 WO2011043740A1 (en) 2009-10-09 2009-10-09 Peptides for inhibition of myd88-dependent signaling pathways

Publications (2)

Publication Number Publication Date
AT510991A2 AT510991A2 (de) 2012-08-15
AT510991A5 true AT510991A5 (de) 2015-02-15

Family

ID=41588681

Family Applications (1)

Application Number Title Priority Date Filing Date
ATA9494/2009A AT510991A5 (de) 2009-10-09 2009-10-09 Peptide für die Inhibition MyD88-abhängiger Signalwege

Country Status (2)

Country Link
AT (1) AT510991A5 (de)
WO (1) WO2011043740A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201319620D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Immunosuppressive agents and their use in therapy

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003057728A1 (en) * 2002-01-10 2003-07-17 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw A novel splice variant of myd88 and uses thereof

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003057728A1 (en) * 2002-01-10 2003-07-17 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw A novel splice variant of myd88 and uses thereof

Also Published As

Publication number Publication date
WO2011043740A1 (en) 2011-04-14
AT510991A2 (de) 2012-08-15

Similar Documents

Publication Publication Date Title
IL261079A (en) Networked LED lighting system
MA46916A (fr) Resttumorinfiltrierende lymphozyten und verfahren zur herstellung und verwendung davon
SG11202010883QA (en) Perfusion bioreactor with filtration systems
DE102014109880A8 (de) Verfahren und Systeme für die emissionsverträgliche Verwendung von telematischen Eingangsgrößen bei einem Antriebssteuerungssystem zur Funktionsumsetzung
PL3227433T3 (pl) Unieśmiertelnione fibroblasty zarodków kurzych
DK3275289T3 (da) LED-belysningssystem
DE102010039955A8 (de) Fertigungsanlage zur Herstellung von Faserverbundmaterial-Bauteilen
ATE476666T1 (de) Verfahren zur identifizierung von glykoformspezifischen antikörpern
SG11201700590UA (en) Water purifying system and filter element management and control method based on water purifying system
BR112017006919A2 (pt) sistema de filtração de combustível inteligente integrado
DE112016003602A5 (de) Optoelektronisches Bauelement umfassend ein Konversionselement, Verfahren zur Herstellung eines optoelektronischen Bauelements umfassend ein Konversionselement und Verwendung eines optoelektronischen Bauelements umfassend ein Konversionselement
UA41838S (uk) Очищувач води
DK3347481T3 (da) Fremgangsmåde til oprensning af biomassehydrolysat
EP3776120A4 (de) Überwachungssystem mit multidrop-backplane-planer
DK3286075T3 (da) Fremgangsmåde til at styre brændstofforbruget af et skib
ZA202100901B (en) Multiplexing of wake-up signals
AT510991A5 (de) Peptide für die Inhibition MyD88-abhängiger Signalwege
DE112013002677A5 (de) Profilsystem zur Befestigung von flexiblen Paneels
IL282865A (en) Non-naturally occurring NKG2D receptors that do not directly signal the cells to which they are attached
DE102017126505A8 (de) Hydrauliksystem für ein Fahrzeug sowie ein Fahrzeug mit einem solchen Hydrauliksystem
DK3938013T3 (da) Automatisk injektionssystem
DE102017001416A8 (de) Vorrichtung zur Erzeugung von Pellets
DK3972389T3 (da) Belysningssystem
DK3350424T3 (da) Dieselmaskine-bypass-(off-line) filtreringssystem med automatisk strømningsstyring
DK3370663T3 (da) Bandage til immobilisering eller fastholdelse af et led

Legal Events

Date Code Title Description
REJ Rejection

Effective date: 20160515